Role of the acid sphingomyelinase/ ceramide system in post-ischemic angiogenesis and brain remodeling
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 161 Seiten
- Language
-
Englisch
- Notes
-
Duisburg, Essen, Universität Duisburg-Essen, Dissertation, 2020
- Keyword
-
Schlaganfall
Tiermodell
Therapie
Ischämie
- Event
-
Veröffentlichung
- (where)
-
Duisburg, Essen
- (who)
-
Universität Duisburg-Essen
- (when)
-
2022
- Creator
- Contributor
- DOI
-
10.17185/duepublico/73097
- URN
-
urn:nbn:de:hbz:465-20220906-144336-7
- Rights
-
Open Access unbekannt; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mohamud Yusuf, Ayan
- Hermann, Dirk Matthias
- Universität Duisburg-Essen
Time of origin
- 2022
Other Objects (12)
Acid sphingomyelinase deficiency ameliorates Farber disease
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner
The acid sphingomyelinase/ceramide system in COVID-19
Role of acid sphingomyelinase in T lymphocyte activation
Acid Sphingomyelinase Is a Modulator of Contextual Fear
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Acid sphingomyelinase is required for efficient phago-lysosomal fusion
Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
Characterization of ARC39, a new inhibitor of acid sphingomyelinase
Identification of novel clinical applications for acid sphingomyelinase inhibitors
Acid sphingomyelinase deficiency ameliorates Farber disease
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner
The acid sphingomyelinase/ceramide system in COVID-19
Role of acid sphingomyelinase in T lymphocyte activation
Acid Sphingomyelinase Is a Modulator of Contextual Fear
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Acid sphingomyelinase is required for efficient phago-lysosomal fusion
Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
Characterization of ARC39, a new inhibitor of acid sphingomyelinase
Identification of novel clinical applications for acid sphingomyelinase inhibitors
Acid sphingomyelinase deficiency ameliorates Farber disease
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
VEGF-induced angiogenesis in the ischemic brain : effect of hyperlipidemia
Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner
The acid sphingomyelinase/ceramide system in COVID-19
Role of acid sphingomyelinase in T lymphocyte activation
Acid Sphingomyelinase Is a Modulator of Contextual Fear
Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
Acid sphingomyelinase is required for efficient phago-lysosomal fusion
Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
Characterization of ARC39, a new inhibitor of acid sphingomyelinase